Amcor plc (AMCR) Released its Q4 2025 Results, Here’s What You Need to Know

Amcor plc (NYSE:AMCR) is one of the Undervalued Cyclical Stocks to Buy According to Hedge Funds. On August 14, Amcor plc (NYSE:AMCR) released its fiscal Q4 2025 results.

Management highlighted its all-stock acquisition of Berry Global, which was completed on April 30. This move expanded the company’s portfolio and led the net sales to reach $5.08 billion, up 43% year-over-year. Moreover, the adjusted EBITDA rose 43% during the same time to reach $789 million.

Amcor plc (AMCR) Released its Q4 2025 Results, Here's What You Need to Know

An automated assembly line producing a variety of packaging products.

For the full year, Amcor plc (NYSE:AMCR) delivered net sales of $15 billion, up 11% year-over-year. Looking ahead, management expects adjusted EPS between $0.8 and $0.83, reflecting a 12% to 17% increase. Moreover, the free cash flow is projected to be between $1.8 billion and $1.9 billion.

Amcor plc (NYSE:AMCR) provides packaging solutions for consumer and healthcare products. It makes sustainable, flexible, and rigid packaging for food, beverages, pharmaceuticals, and personal care items.

While we acknowledge the potential of AMCR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMCR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.